Federal officials have made their final decision: Medicare will only pay for patients to get the new Alzheimer's drug aducanumab (Aduhelm) if the patients are participating in clinical trials.
from WebMD Health https://www.webmd.com/alzheimers/news/20220408/medicare-will-only-cover-new-alzheimers-drug-in-trials?src=RSS_PUBLIC
0 Comments:
Post a Comment